Indication: Infantile Spasms
A Phase 2 Study to Assess the Safety, Tolerability, Exploratory Efficacy, and Pharmacokinetics of Orally Administered JBPOS0101 for Refractory Infantile Spasms Patients
Sub-indication: Infantile Spasms
Principal Investigator: Vinay Puri, M.D.Norton Children's Neuroscience Institute, affiliated with the UofL School of Medicine
Sponsor: Bio-Pharm Solutions Co., Ltd.